Breaking AI & Tech News Analyzed

The Lead Anthropic, the AI lab behind Claude, has filed confidentially for an initial public offering (IPO). The company, valued at close to $1 trillion, submitted a draft registration statement to the U.S. Securities and Exchange Commission. IPO Filing Details The filing comes less than a week after Anthropic raised $65 billion in a Series H funding round that pushed its valuation to $965 billion. The proposed initial public offering will depend on market conditions and other factors. Anthropic has yet to list the number of shares or set the price. The Funding Round Anthropic raised $65 billion in a Series H funding round. The round was co-led by Altimeter Capital, Dragoneer, Greenoaks, Sequoia Capital, Capital Group, Coatue, and D1 Capital Partners. IPO Season and Market Impact The filing comes as SpaceX is targeting a $2 trillion valuation for its own IPO, seeking to raise more than $75 billion. Anthropic's rival OpenAI is also preparing for an IPO, having raised $122 billion in March at an $852 billion post-money valuation. Anthropic's Growth and Future Outlook Anthropic's revenue run-rate has surpassed $47 billion, up from $9 billion at the end of 2025. The company is poised to give the European Union's cybersecurity agency access to its Mythos model, which could accelerate revenue growth. The Prediction Anthropic's confidential IPO filing sets the stage for a competitive IPO season between the two largest AI labs, testing the market's interest in artificial intelligence. If Anthropic follows through with the IPO, it will file an S-1 registration document with detailed financial information.

Executive Summary: Nvidia Unveils RTX Spark Superchip for AI‑Powered PCsNvidia introduced the RTX Spark superchip, a hybrid processor that embeds on‑device AI capabilities into consumer laptops and desktops, promising to “reinvent the PC” for the AI era.RTX Spark Superchip Brings On‑Device AI to Laptops and DesktopsSpeaking at the Computex conference in Taiwan, CEO Jensen Huang said the chip will be integrated by OEMs such as Dell, Lenovo, Asus and HP and paired with Microsoft Windows. Developed with help from Taiwan’s MediaTek, the chip combines a microprocessor and graphics core to run AI agents locally, eliminating the need for cloud reliance.Launch timeline: slated for release later in 2026.Target devices: thin‑and‑light laptops and desktop PCs.Key capability: autonomous navigation of the PC, potentially replacing mouse and keyboard interactions.Financial and Competitive Landscape SnapshotThe announcement comes from a $5tn (≈£3.7tn) U.S. semiconductor giant that already dominates the AI data‑center market. Competitors are responding quickly:Intel plans to ship its AI‑focused GPU Xe3P (“Crescent Island”) later this year, using cheaper memory and cooling solutions.Apple, Qualcomm and AMD are also positioned to contest the emerging edge‑AI PC segment.Implications for the PC Ecosystem and Chip WarsThe move expands Nvidia’s reach beyond graphics cards into full‑system computing, opening a new consumer‑oriented revenue line. Analysts liken the “RTX Spark moment” to the disruptive impact of the iPhone, ChatGPT and DeepSeek, suggesting a transition from app‑centric PCs to “agentic AI personal computers.”Industry observers note that while the launch is strategically significant, investors may view it as a longer‑term growth driver rather than an immediate earnings boost, given Nvidia’s continued reliance on data‑center demand.Future Outlook: Edge AI PCs and Market DynamicsExperts predict that as edge AI agents become pivotal, AI‑enabled PCs could become commonplace in households within the next few years. Nvidia’s parallel development of the Vera CPU, aimed at AI agents for early adopters like OpenAI and SpaceX, reinforces its commitment to a unified AI hardware stack.Meanwhile, rival Arm is pursuing an ambitious compensation plan for CEO Rene Haas that could make him a billionaire if the firm reaches a trillion‑dollar valuation, underscoring the high stakes of the broader chip war.

The Lead: Anthropic's Historic ValuationAnthropic, the AI firm behind the Claude chatbot, announced on Thursday it had raised $65bn in funding to value the company at $965bn post-money. The move makes Anthropic the world's most valuable AI startup, eclipsing its competitor OpenAI.The Rise of a New AI PowerhouseThe deal marks an exceedingly successful period of growth for Anthropic, which was once considered to be a smaller player in the global AI arms race. The widespread adoption of its products by large enterprise businesses, especially following its release of powerful coding assistants late last year, has turned it into a dominant player in the industry.Financial Impact: A Reshuffled AI IndustryAnthropic's new valuation cements a reshuffling of the AI industry's power dynamics, putting a dollar figure on Claude's increased cultural and commercial prominence. The deal is also likely to have implications for this year's blockbuster slate of initial public offerings, which includes rivals OpenAI and SpaceX.Industry Implications: Safety Focus vs. Market DominanceIn addition to orienting its business more towards enterprise and coding services than some of its consumer-forward competitors, Anthropic has also postured itself as a more safety-focused company. One of Anthropic's co-founders was present earlier this month at Pope Leo's release of a more than 43,000-word encyclical which warned against the dangers of AI and called for a reining-in of the technology.The firm is also still locked in a legal battle with the Pentagon following its refusal earlier this year to remove safeguards that would allow Claude to be used for mass domestic surveillance or lethal autonomous weapons systems, which could kill people without human input.Future Outlook: Geopolitical and Political InfluenceThe White House was forced to ease its feud with Anthropic somewhat in recent weeks, however, after the company announced that it was withholding the release of its latest Mythos model over cybersecurity concerns. The episode sparked a small-scale geopolitical crisis as nations worried about vulnerabilities to financial systems and critical infrastructure.Anthropic is additionally set to be an influential force in the US midterm elections, pouring millions into lobbying efforts and Super Pacs aimed at candidates and legislation that aligns with its views on regulating AI. The firm has called for more government oversight of the technology, breaking with other tech industry leaders and OpenAI which advocate for a more lax regulatory framework.The AI Funding Race ContinuesThe company's valuation underscores the enormous amounts of money still flowing into the AI industry, despite widespread public distrust of the technology. Anthropic's valuation follows OpenAI raising $122bn in March to be valued at $852bn, with the possibility it will seek a $1tn IPO later this year.

The AI Startup Valuation ShiftAnthropic has usurped OpenAI as the world's most valuable artificial intelligence startup, soaring to a $965bn valuation ahead of expected public listings by the rival firms. Anthropic, the maker of the Claude family of chatbots, said on Thursday that it had raised $65bn from private investors after a fundraising round led by Altimeter Capital, Greenoaks, Dragoneer and Sequoia Capital.Funding and Leadership PositionThe announcement catapults Anthropic, led by CEO and cofounder Dario Amodei, ahead of ChatGPT maker OpenAI in value, which attracted an $852bn valuation in its last fundraising round in March. "This funding will help us serve the historic demand we are experiencing, stay at the research frontier, and bring Claude to more of the places where work happens," Anthropic's Chief Financial Officer Krishna Rao said in a statement.Market Recognition and AdoptionAltimeter Capital CEO Brad Gerstner hailed the adoption of Claude among the "world's most demanding organisations" as evidence of Anthropic's command in the field. "This momentum positions Anthropic to lead the next phase of AI innovation and capture the enormous opportunity ahead," Gerstner said.Rapid Growth and Market PositionFounded in 2021 by former OpenAI researchers, Anthropic has rapidly emerged as one of the leading players in Silicon Valley's scramble to dominate AI. Anthropic's Claude, first launched in 2023, is among the most popular AI models worldwide. In March, the San Francisco-based company said that the chatbot was receiving more than 1 million new sign-ups each day.Challenges and Recent DevelopmentsWhile achieving stellar success in rapid time, Anthropic has also faced challenges – in particular, a high-profile dispute with US President Donald Trump's administration, which has labelled the firm a "supply chain risk" over its refusal to allow unrestricted access to its tools for military purposes. Anthropic unveiled its latest iteration of Claude, Opus 4.8, in a separate announcement on Thursday, calling it a "modest but tangible improvement" on its predecessor.Future Outlook and Market DynamicsAnthropic, OpenAI and Elon Musk's rocket company SpaceX are all expected to go public in the near future in what are expected to be among the biggest initial public offerings in history. Jay R Ritter, an emeritus professor at the University of Florida who specialises in IPOs, said Anthropic has generated a lot of market excitement due to its widespread use by companies for software coding. "This is a big market where apparently Anthropic has the best product," Ritter told Al Jazeera.Valuation Trends and Market Analysis"The increase in valuation in a short period of time is unprecedented for a startup, although publicly traded tech companies such as SK Hynix, Nvidia, and Alphabet have seen even bigger increases, although not as much in percentage terms," Ritter said, referring to the South Korean and US chip giants, and Google's parent company. While it remains to be seen whether the massive investments pouring into AI are creating a bubble, Ritter said, the handful of successful firms that are likely to emerge in the field could see enormous profits.Industry Consolidation and Future Prospects"Nobody wants to use the eighth best product, so these companies are either one of the handful of successful firms, or they will have a zero market share," he said. "The tech industry is different than the restaurant industry, where there are not large economies of scale, and where competition limits the profit margins."

The Lead This week at TechCrunch’s StrictlyVC event in Athens, I sat down with three top VCs to discuss the current state of venture investing, the wave of mega-IPOs, and where they see opportunities in AI. VC Insights on AI and Mega-IPOs The conversation featured Niko Bonatsos of Verdict Capital, Andreas Stavropoulos of Threshold Ventures, and Ben Blume of Atomico. They discussed the potential impact of SpaceX's reported $1.75 trillion valuation at IPO, as well as the opportunities and challenges in the AI space. The Data Analysis SpaceX's potential $1.75 trillion valuation at IPO OpenAI and Anthropic potentially not far behind in terms of valuation Three-quarters of all venture capital raised over the last year went into five companies $500 million fund looking at the same opportunities as people investing from a $10 billion or $15 billion fund The Impact Analysis The VCs discussed how the current flood of capital into AI may be justified by future earnings, but also acknowledged the risk of extreme FOMO (fear of missing out). They also touched on the challenges of pricing deals when things are moving fast and the importance of looking beyond age as a proxy for entrepreneurial potential. The Prediction The VCs see opportunities in areas such as consumer fintech, AI interacting with the physical world, and robotics. They predict that the next generation of companies will be able to go after much larger markets and that immigrant founders will continue to play a significant role in driving innovation.

The LeadBlue Origin's New Glenn rocket exploded during a test in Florida on Thursday, an incident which the aerospace company called an "anomaly." All personnel have been accounted for, and the company has promised to provide updates as they learn more about what caused the explosion.The Explosion DetailsA livestream posted by NSF, an aerospace news organization, captured the fiery plume of the explosion. Homes shook in nearby Cape Canaveral and Cocoa Beach around 9pm, with residents turning to social media to ask what happened. Cape Canaveral Space Force Station's Launch Complex 36 is visible from the beach, and the internet quickly filled with photos of the orange fireball. Emergency officials confirmed there was no threat due to fumes or other potential hazards.Recent Setbacks for Blue OriginThis explosion marks another setback for Blue Origin, which is owned by Amazon founder Jeff Bezos. The New Glenn rocket was already grounded in April, as the Federal Aviation Administration required Blue Origin to investigate an engine mishap. The FAA has not yet commented on whether Thursday's explosion will trigger another investigation.Industry Competition ImplicationsThe incident comes at a critical time for Blue Origin's space ambitions. Earlier this week, NASA announced it had chosen Blue Origin over Elon Musk's SpaceX to conduct the first of three uncrewed lunar missions this year to kickstart construction of a $20 billion moon base. Both companies are competing to provide crew landers for upcoming Artemis missions, including the planned 2028 return of humans to the moon on Artemis IV. Both companies have built large new facilities in or close to Cape Canaveral's Kennedy Space Center to support crewed and cargo missions in partnership with NASA.Future Outlook for Blue OriginDespite the explosion, Blue Origin's space ambitions remain significant. The company has a vested interest in space tourism, having sent an all-female, star-studded crew including Gayle King and Katy Perry into space last April. Elon Musk, whose SpaceX lost the NASA contract to Blue Origin, commented on the incident, writing "Most unfortunate. Rockets are hard." This latest explosion may delay Blue Origin's timeline but is unlikely to derail their long-term space exploration goals, though it may create opportunities for competitors like SpaceX to gain ground in the increasingly competitive private space race.

Lead: NASA’s New Moon‑Base MilestoneNASA revealed that Blue Origin will conduct the first uncrewed lunar lander mission in a series of three scheduled for 2026, marking the agency’s initial move toward a $20 bn moon base. The decision, announced by NASA Administrator Jared Isaacman, places Bezos’s company ahead of SpaceX for this critical early contract.Blue Origin Secures First Uncrewed Moon Base MissionThe award designates Blue Origin’s Endurance cryogenic cargo lander to deliver scientific payloads to the Shackleton‑de Gerlache Ridge at the lunar south pole. The mission, targeted for launch as early as fall 2026, will be the first privately funded lunar lander flight in history.Contract awarded to Blue Origin over competing bids.Mission to test critical capabilities for future human‑landing systems.Part of a broader NASA roadmap that includes more than a dozen additional lunar missions through the decade.Financial Terms and Timeline of the 2026 Lunar MissionsNASA has allocated $230.4 million for each of the first two moon‑base missions, with the agency covering the majority of operational costs.Funding per mission: $230.4 million.2026 schedule: Three uncrewed missions, followed by “more than a dozen” missions in subsequent years.Related contracts: Smaller awards to Lunar Outpost, Firefly Aerospace, and other private firms supporting lunar‑to‑Mars projects.Strategic Implications for U.S. Lunar Ambitions and Private Space CompetitionThe selection underscores the Trump administration’s push to accelerate the Artemis program and establish a permanent lunar presence ahead of China. By leveraging private industry, NASA aims to lower taxpayer costs, stimulate a space‑economy job market, and maintain U.S. leadership in deep‑space exploration.Creates a direct competitive dynamic between Blue Origin and SpaceX for future crewed lander contracts (Artemis III, Artemis IV).Supports the “blueprint for an enduring lunar presence” with a target of operational capability by 2029‑2032.Aligns with national space policy goals of a “golden age of exploration” and a semi‑permanent lunar settlement.What Lies Ahead for NASA’s Moon Base and Commercial Lander DevelopmentFollowing the 2026 uncrewed flights, NASA will evaluate the performance of both Blue Origin’s Blue Moon lander and SpaceX’s Starship HLS during the Artemis III test mission in low‑Earth orbit. Successful demonstrations are expected to pave the way for crewed landings on Artemis IV (planned for 2028) and the eventual construction of Moon Base One.Industry observers anticipate that continued private‑sector involvement will accelerate technology maturation, reduce launch costs, and expand the commercial market for lunar payload services, setting the stage for a sustained human presence on the Moon.

The Lease Duration Dispute A controversy has arisen regarding the length of Anthropic's lease with SpaceX, a deal that involves billions of dollars a month for exclusive use of Anthropic's Colossus cluster. Elon Musk claimed on X that the lease is for 180 days with a 90-day notice for mutual cancellation, while SpaceX's recent S-1 filing presents the deal as a three-year agreement. The Details of the Deal According to Musk, the short-term lease was SpaceX's request, not Anthropic's. He stated that SpaceX won't leave Anthropic hanging and will provide a reasonable off-ramp, but might need the compute capacity back if it gets super tight. On the other hand, SpaceX's S-1 filing confirms a 90-day cancellation notice but describes the agreement as lasting through May 2029, with a monthly fee. The Data Analysis The deal involves a significant monthly fee of $1.25 billion, as mentioned in the S-1 filing. This substantial commitment highlights the importance of the compute capacity for both parties. The Impact Analysis The discrepancy between Musk's statement and SpaceX's filing raises questions about the accuracy of the information provided. This situation could be seen as a material misrepresentation made while marketing a security, which could have implications for investors and the companies involved. The Prediction The future of the lease and the relationship between Anthropic and SpaceX will depend on how this situation unfolds. With the SEC possibly involved, the companies will need to clarify the terms of the agreement to avoid any further controversy.

On 15 May, **BioOrbit** launched its compact **Box‑E** payload aboard a **SpaceX** rocket, beginning a six‑week orbital trial to grow ultra‑pure protein crystals for self‑injectable cancer therapies. Box‑E’s Orbital Test: Microgravity Enables Ultra‑Pure Protein Crystals The microwave‑sized unit will float aboard the International Space Station, where microgravity eliminates the disruptive effects of Earth’s gravity on crystal formation. The resulting crystals are more stable, allowing drug formulations that are impossible to achieve on the ground. Mission duration: ~6 weeks in orbit Target output: thousands of litres of fluid per box per year Goal: Produce cancer‑drug crystals that can be stored in a fridge and self‑injected £9.8 Million Funding Round and UK Space Agency Contract Last month **BioOrbit** closed a **£9.8 million** Series A round led by **LocalGlobe** and **Breega**, earmarked for the orbital test and scaling of the hardware. Earlier in March the company secured a **£250,000** contract from the UK Space Agency to manufacture drugs in microgravity. Potential Disruption of Cancer Treatment Delivery Current immunotherapies such as Merck’s **Keytruda** require lengthy IV infusions in hospitals. By crystallising the active protein, **Box‑E** could enable high‑concentration, low‑viscosity formulations suitable for pen‑injectors, reducing treatment time from hours to minutes and extending shelf‑life. Roadmap to Commercialisation and Market Size **BioOrbit** projects that, if orbital tests succeed, multiple **Box‑E** units could be stacked to meet the demand of a blockbuster drug within a handful of boxes. The company estimates a market of **$22.7 trillion** for in‑space manufacturing across sectors, with pharmaceuticals a key segment. Clinical trials and regulatory approval are expected to take at least five years before the new formulations reach patients. Future Outlook for Space‑Based Pharma Beyond cancer, the crystallisation platform could be applied to the roughly 70 % of top‑selling drugs that are currently administered intravenously. Partnerships with major pharma groups are already being explored, and competitors such as **Varda Space Industries** are also pursuing in‑orbit drug processing, signaling a burgeoning industry.